You are here: Industry Insights > COVID-19

News List

Gilead scouting for partners in India, Pak for remdesivir expresspharma
May 08, 2020
Recent clinical trial results and the decision by the US Food and Drug Administration (FDA) to issue ”Emergency Use Authorisation” for remdesivir have highlighted the urgency of this work and the importance of planning for access to remdesivir globally.
Government to conduct randomised controlled clinical trial of Ashwagandha expresspharma
May 08, 2020
This will be a joint initiative of the ministries of AYUSH, Health and Science and Technology through the CSIR and with technical support from ICMR.
EMA Initiates ‘Rolling Review’ of Remdesivir, Potential COVID-19 Treatment europeanpharmaceuticalreview
May 07, 2020
The EMA’s human medicines committee has announced it has begun a rolling review of remdesivir for the treatment of COVID-19, to examine its safety and effectiveness.
First Patient Dosed With Pfizer’s Potential COVID-19 Vaccine in US europeanpharmaceuticalreview
May 07, 2020
Pfizer and BioNTech have initiated Phase I/II trials in the US to determine the safety and optimal dose of four mRNA COVID-19 vaccine candidates.
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine americanpharmaceuticalreview
May 07, 2020
INOVIO has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG.
AstraZeneca, Oxford University Announce Agreement for COVID-19 Vaccine americanpharmaceuticalreview
May 07, 2020
AstraZeneca and the University of Oxford announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.
NYU Langone to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine americanpharmaceuticalreview
May 07, 2020
The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease.
Integral Molecular Develops Test for Neutralizing COVID-19 Antibodies americanpharmaceuticalreview
May 07, 2020
Integral Molecular announces the launch of SARS-CoV-2 Reporter Virus Particles (RVPs).
Aberdeen Uni proceeds with COVID-19 mass screening research pharmatimes
May 07, 2020
Researchers at the University of Aberdeen plan to use artificial intelligence (AI) to try to fast-track a test to allow mass screening for COVID-19, after the £140,000 project was approved by the Scottish government.
NICE joins international COVID-19 pandemic response pharmatimes
May 07, 2020
The National Institute for Health and Care Excellence (NICE) says it is supporting a growing number of international collaborations striving to share knowledge and identify new treatments in response to the COVID-19 pandemic.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page